Howze Yalonda's Form 4 filing
Codiak BioSciences, Inc.CDAK · filed Mar 30, 2023
- Accession no.
- 0000950170-23-011055
- Filed
- Mar 30, 2023, 6:01 PM ET
- Trade date
- Mar 30, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $318.27. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Howze YalondaCIK 0001828153 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | Common Stock | SSaleDisposed | −1,628 | $0.1955 | −$318.27 | 7,458 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary